Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) were down 23.3% during trading on Saturday . The stock traded as low as C$0.12 and last traded at C$0.12. Approximately 1,797,794 shares traded hands during trading, an increase of 540% from the average daily volume of 280,948 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Price Performance
The stock has a market capitalization of C$18.65 million, a PE ratio of -3.55 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The stock’s 50-day moving average is C$0.10 and its 200 day moving average is C$0.13.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Why Invest in 5G? How to Invest in 5G Stocks
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Invest in Blue Chip Stocks
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
